Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-171,884
Closed -$2.17M 60
2025
Q4
$2.17M Sell
171,884
-17,160
-9% -$253K 0.42% 43
2025
Q3
$2.91M Sell
189,044
-936
-0.5% -$15.1K 0.52% 38
2025
Q2
$2.99M Buy
189,980
+1,154
+0.6% +$17.5K 0.59% 39
2025
Q1
$3.61M Buy
188,826
+2,049
+1% +$44.8K 0.84% 34
2024
Q4
$4.45M Sell
186,777
-2,060
-1% -$57.5K 0.96% 31
2024
Q3
$5.29M Sell
188,837
-852
-0.4% -$24.1K 1.18% 27
2024
Q2
$4.96M Buy
189,689
+2,929
+2% +$60.9K 1.19% 28
2024
Q1
$4.08M Sell
186,760
-2,162
-1% -$46.3K 0.98% 29
2023
Q4
$4.39M Sell
188,922
-2,793
-1% -$56.2K 1.15% 30
2023
Q3
$3.78M Buy
191,715
+653
+0.3% +$12.9K 1.07% 31
2023
Q2
$4.33M Buy
191,062
+1,035
+0.5% +$20.8K 1.2% 31
2023
Q1
$3.73M Sell
190,027
-515
-0.3% -$9.88K 1.16% 32
2022
Q4
$3.28M Buy
+190,542
New +$3.38M 1.02% 35

Other funds holding RXO

Kirr Marbach & Co's RXO Position: Q1 2026 in Review

Kirr Marbach & Co sold out of RXO (RXO) in Q1 2026, closing a stake of 171,884 shares — an estimated $2.17M sold.

Kirr Marbach & Co first reported a position in RXO in Q4 2022 and held it in 13 quarters. The position peaked at $5.29M in Q3 2024. 275 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Kirr Marbach & Co reported no remaining RXO position as of Q1 2026 after selling out during the quarter.
  • Kirr Marbach & Co sold 171,884 RXO shares in Q1 2026, an estimated $2.17M.
  • Kirr Marbach & Co first reported a position in RXO in Q4 2022 and held it in 13 quarters.
  • Kirr Marbach & Co's RXO position peaked at $5.29M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Kirr Marbach & Co's 13F filing for Q1 2026, filed 17 Apr 2026.